Onderneming Zymergen Inc.
Aandelen
ZY
US98985X1000
Biotechnologie & Medisch Onderzoek
Vakgebied
Aantal werknemers: 505
Verkoop per activiteit
USD in miljoen | 2020 | Gewicht | 2021 | Gewicht | Delta |
---|---|---|---|---|---|
Research and Development Service Agreements
74,1
%
| 10 | 73,7 % | 12 | 74,1 % | +26,83% |
Collaboration
25,9
%
| 3 | 26,3 % | 4 | 25,9 % | +23,90% |
Verkoop per regio
USD in miljoen | 2020 | Gewicht | 2021 | Gewicht | Delta |
---|---|---|---|---|---|
United States
40,6
%
| 6 | 45,9 % | 7 | 40,6 % | +11,32% |
Europe
30,7
%
| 2 | 18,4 % | 5 | 30,7 % | +110,64% |
Asia
28,7
%
| 5 | 35,7 % | 5 | 28,7 % | +1,37% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Zachariah Serber
FOU | Founder | 49 | 01-04-13 |
Jay Flatley
CHM | Chairman | 71 | 01-01-20 |
Dmitriy Ryaboy
CTO | Chief Tech/Sci/R&D Officer | - | - |
Lincoln Germain
PRN | Corporate Officer/Principal | - | 05-08-21 |
Corporate Officer/Principal | - | 05-08-21 | |
Judy Gilbert
HRO | Human Resources Officer | - | 01-03-17 |
Aindrea Campbell
PRN | Corporate Officer/Principal | - | 04-05-21 |
Mina Kim
LAW | General Counsel | 50 | 01-01-20 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Steven J. Chu
BRD | Director/Board Member | 76 | 01-07-16 |
Director/Board Member | 67 | 01-03-21 | |
Jay Flatley
CHM | Chairman | 71 | 01-01-20 |
Rohit Sharma
BRD | Director/Board Member | 55 | 01-06-15 |
Sandra Peterson
BRD | Director/Board Member | 65 | 01-12-19 |
Matthew Ocko
BRD | Director/Board Member | 55 | 01-06-15 |
Zachariah Serber
FOU | Founder | 49 | 01-04-13 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 104 355 336 | 97 958 911 ( 93,87 %) | 0 | 93,87 % |
Bedrijfsgegevens
Sector
Verkoop per activiteit
Verkoop per regio
Vaira. 1 jan. | Kapi. | |
---|---|---|
+8,90% | 45,97 mld. | |
+52,33% | 43,93 mld. | |
+7,87% | 42,34 mld. | |
-8,78% | 28,27 mld. | |
+18,09% | 27,18 mld. | |
-20,80% | 19,44 mld. | |
+14,67% | 13,83 mld. | |
+31,78% | 12,4 mld. | |
+9,29% | 11,45 mld. |